Cargando…

Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea

BACKGROUND: The quality-of-life of patients with irritable bowel syndrome is low; incorrect diagnosis/treatment causes economic burden and inappropriate consumption of medical resources. This survey-based study aimed to analyze the current status of irritable bowel syndrome treatment to examine diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Hoon Sup, Son, Hui Chang, Lee, Hong Sub, Goong, Hyeon Jeong, Kim, Ju Seok, Kim, Ki Bae, Kwon, Yong Hwan, Kim, Jae Hak, Shin, Hyun Deok, Shin, Ji Eun, Jee, Sam Ryong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125791/
https://www.ncbi.nlm.nih.gov/pubmed/37096309
http://dx.doi.org/10.3346/jkms.2023.38.e126
_version_ 1785030100144619520
author Koo, Hoon Sup
Son, Hui Chang
Lee, Hong Sub
Goong, Hyeon Jeong
Kim, Ju Seok
Kim, Ki Bae
Kwon, Yong Hwan
Kim, Jae Hak
Shin, Hyun Deok
Shin, Ji Eun
Jee, Sam Ryong
author_facet Koo, Hoon Sup
Son, Hui Chang
Lee, Hong Sub
Goong, Hyeon Jeong
Kim, Ju Seok
Kim, Ki Bae
Kwon, Yong Hwan
Kim, Jae Hak
Shin, Hyun Deok
Shin, Ji Eun
Jee, Sam Ryong
author_sort Koo, Hoon Sup
collection PubMed
description BACKGROUND: The quality-of-life of patients with irritable bowel syndrome is low; incorrect diagnosis/treatment causes economic burden and inappropriate consumption of medical resources. This survey-based study aimed to analyze the current status of irritable bowel syndrome treatment to examine differences in doctors’ perceptions of the disease, and treatment patterns. METHODS: From October 2019 to February 2020, the irritable bowel syndrome and Intestinal Function Research Study Group of the Korean Society of Neurogastroenterology and Motility conducted a survey on doctors working in primary, secondary, and tertiary healthcare institutions. The questionnaire included 37 items and was completed anonymously using the NAVER platform (a web-based platform), e-mails, and written forms. RESULTS: A total of 272 doctors responded; respondents reported using the Rome IV diagnostic criteria (amended in 2016) for diagnosing and treating irritable bowel syndrome. Several differences were noted between the primary, secondary, and tertiary physicians’ groups. The rate of colonoscopy was high in tertiary healthcare institutions. During a colonoscopy, the necessity of random biopsy was higher among physicians who worked at tertiary institutions. ‘The patient did not adhere to the diet’ as a reason for ineffectiveness using low-fermentable oligo-, di-, and mono-saccharides, and polyols diet treatment was higher among physicians in primary/secondary institutions, and ‘There are individual differences in terms of effectiveness’ was higher among physicians in tertiary institutions. In irritable bowel syndrome constipation predominant subtype, the use of serotonin type 3 receptor antagonist (ramosetron) and probiotics was higher in primary/secondary institutions, while serotonin type 4 receptor agonist was used more in tertiary institutions. In irritable bowel syndrome diarrhea predominant subtype, the use of antispasmodics was higher in primary/secondary institutions, while the use of serotonin type 3 receptor antagonist (ramosetron) was higher in tertiary institutions. CONCLUSION: Notable differences were observed between physicians in primary/secondary and tertiary institiutions regarding the rate of colonoscopy, necessity of random biopsy, the reason for the ineffectiveness of low-fermentable oligo-, di-, and mono-saccharides, and polyols diet, and use of drug therapy in irritable bowel syndrome. In South Korea, irritable bowel syndrome is diagnosed and treated according to the Rome IV diagnostic criteria, revised in 2016.
format Online
Article
Text
id pubmed-10125791
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-101257912023-04-26 Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea Koo, Hoon Sup Son, Hui Chang Lee, Hong Sub Goong, Hyeon Jeong Kim, Ju Seok Kim, Ki Bae Kwon, Yong Hwan Kim, Jae Hak Shin, Hyun Deok Shin, Ji Eun Jee, Sam Ryong J Korean Med Sci Original Article BACKGROUND: The quality-of-life of patients with irritable bowel syndrome is low; incorrect diagnosis/treatment causes economic burden and inappropriate consumption of medical resources. This survey-based study aimed to analyze the current status of irritable bowel syndrome treatment to examine differences in doctors’ perceptions of the disease, and treatment patterns. METHODS: From October 2019 to February 2020, the irritable bowel syndrome and Intestinal Function Research Study Group of the Korean Society of Neurogastroenterology and Motility conducted a survey on doctors working in primary, secondary, and tertiary healthcare institutions. The questionnaire included 37 items and was completed anonymously using the NAVER platform (a web-based platform), e-mails, and written forms. RESULTS: A total of 272 doctors responded; respondents reported using the Rome IV diagnostic criteria (amended in 2016) for diagnosing and treating irritable bowel syndrome. Several differences were noted between the primary, secondary, and tertiary physicians’ groups. The rate of colonoscopy was high in tertiary healthcare institutions. During a colonoscopy, the necessity of random biopsy was higher among physicians who worked at tertiary institutions. ‘The patient did not adhere to the diet’ as a reason for ineffectiveness using low-fermentable oligo-, di-, and mono-saccharides, and polyols diet treatment was higher among physicians in primary/secondary institutions, and ‘There are individual differences in terms of effectiveness’ was higher among physicians in tertiary institutions. In irritable bowel syndrome constipation predominant subtype, the use of serotonin type 3 receptor antagonist (ramosetron) and probiotics was higher in primary/secondary institutions, while serotonin type 4 receptor agonist was used more in tertiary institutions. In irritable bowel syndrome diarrhea predominant subtype, the use of antispasmodics was higher in primary/secondary institutions, while the use of serotonin type 3 receptor antagonist (ramosetron) was higher in tertiary institutions. CONCLUSION: Notable differences were observed between physicians in primary/secondary and tertiary institiutions regarding the rate of colonoscopy, necessity of random biopsy, the reason for the ineffectiveness of low-fermentable oligo-, di-, and mono-saccharides, and polyols diet, and use of drug therapy in irritable bowel syndrome. In South Korea, irritable bowel syndrome is diagnosed and treated according to the Rome IV diagnostic criteria, revised in 2016. The Korean Academy of Medical Sciences 2023-04-05 /pmc/articles/PMC10125791/ /pubmed/37096309 http://dx.doi.org/10.3346/jkms.2023.38.e126 Text en © 2023 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Koo, Hoon Sup
Son, Hui Chang
Lee, Hong Sub
Goong, Hyeon Jeong
Kim, Ju Seok
Kim, Ki Bae
Kwon, Yong Hwan
Kim, Jae Hak
Shin, Hyun Deok
Shin, Ji Eun
Jee, Sam Ryong
Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title_full Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title_fullStr Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title_full_unstemmed Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title_short Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea
title_sort survey-based analysis of the clinical treatment status of irritable bowel syndrome in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125791/
https://www.ncbi.nlm.nih.gov/pubmed/37096309
http://dx.doi.org/10.3346/jkms.2023.38.e126
work_keys_str_mv AT koohoonsup surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT sonhuichang surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT leehongsub surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT goonghyeonjeong surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT kimjuseok surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT kimkibae surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT kwonyonghwan surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT kimjaehak surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT shinhyundeok surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT shinjieun surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea
AT jeesamryong surveybasedanalysisoftheclinicaltreatmentstatusofirritablebowelsyndromeinkorea